![Hiromichi Kimura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hiromichi Kimura
Chief Executive Officer at
Fast Track Initiative, Inc.
Profile
Hiromichi Kimura is the founder of Fast Track Initiative Inc, founded in 2004, serving as CEO and Managing Partner.
Current jobs include Executive Director & Chief Scientific Officer at The Children's Mercy Hospital; President, Representative Director & Partner at Life Science Management, Inc. since 2000; Director at AccuRna, Inc., HanaVax, Inc., and NeoPhore Ltd.; Outside Director at Braizon Therapeutics, Inc.; and Investment Director at Astellas Venture Management LLC since 2018.
Former jobs include Associate Director & Head-Research at Millennium Pharmaceuticals, Inc. from 2013 to 2014; Associate Director & Research head at Takeda Pharmaceutical Co., Ltd. from 2007 to 2014; President & Representative Director at HuBit Genomix KK; Senior Director at Astellas Pharma, Inc. from 2014 to 2018; President & Representative Director at Monsanto Japan Ltd.; Director at CellSeed, Inc. from 2001 to 2011; and Director at CYTLIMIC, Inc. Education includes graduate and doctorate degrees from the University of Tokyo and an MBA from Stanford University.
Hiromichi Kimura active positions
| Companies | Position | Start |
|---|---|---|
Fast Track Initiative, Inc.
 Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative invests in companies located in Japan and the United States. The firm targets companies operating in the fields of the life science community including therapeutics, diagnostics, digital health, healthcare services, and more sectors. It provides financing for seed and early stages capital requirements. It also makes follow-on investments. | Chief Executive Officer | 19/03/2004 |
Life Science Management, Inc.
 Life Science Management, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in consulting services for life science and healthcare related business | President | 01/08/2000 |
AccuRna, Inc.
 AccuRna, Inc. BiotechnologyHealth Technology Researches and develops nucleic acid-based drugs using drug delivery system technologies | Director/Board Member | - |
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology Develops nasal vaccine against infectious diseases | Director/Board Member | - |
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management invests in companies located across the globe. The firm focuses on companies operating in the fields of biotechnology, including drug discovery and development. It provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2018 |
Braizon Therapeutics, Inc.
 Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drugs | Director/Board Member | - |
The Children's Mercy Hospital
 The Children's Mercy Hospital Hospital/Nursing ManagementHealth Services Provides pediatric health care services | Corporate Officer/Principal | - |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Director/Board Member | - |
Former positions of Hiromichi Kimura
| Companies | Position | End |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 31/12/2018 |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ | - |
Training of Hiromichi Kimura
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
HuBit Genomix KK
 HuBit Genomix KK Miscellaneous Commercial ServicesCommercial Services Researches genes, particularly single nucleotide polymorphisms, or SNPs, and disease, for use in the development of therapeutics and diagnostics | Commercial Services |
Astellas Pharma, Inc.
 Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
The Children's Mercy Hospital
The Children's Mercy Hospital Hospital/Nursing ManagementHealth Services Provides pediatric health care services | Health Services |
Monsanto Japan Ltd.
 Monsanto Japan Ltd. Chemicals: AgriculturalProcess Industries Manufactures a wide range of genetically altered seeds, fertilizers and agrocheimcals | Process Industries |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management invests in companies located across the globe. The firm focuses on companies operating in the fields of biotechnology, including drug discovery and development. It provides financing for early stage capital requirements. | Finance |
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative invests in companies located in Japan and the United States. The firm targets companies operating in the fields of the life science community including therapeutics, diagnostics, digital health, healthcare services, and more sectors. It provides financing for seed and early stages capital requirements. It also makes follow-on investments. | Finance |
CellSeed, Inc.
 CellSeed, Inc. Pharmaceuticals: OtherHealth Technology Engages in the cell sheet regenerative medicine and intelligent cell culture ware products businesses | Health Technology |
Life Science Management, Inc.
Life Science Management, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in consulting services for life science and healthcare related business | Commercial Services |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology Researches and develops nucleic acid-based drugs using drug delivery system technologies | Health Technology |
CYTLIMIC, Inc.
 CYTLIMIC, Inc. BiotechnologyHealth Technology Develops immunotherapy products for the treatment of cancer | Health Technology |
HanaVax, Inc.
HanaVax, Inc. BiotechnologyHealth Technology Develops nasal vaccine against infectious diseases | Health Technology |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Commercial Services |
Braizon Therapeutics, Inc.
Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drugs | Commercial Services |
- Stock Market
- Insiders
- Hiromichi Kimura
